Counterfactual Decomposition of Health Care Expenditures: From Cost-Based Payment to a Global Budget System

References

Addis, A., and N. Magrini. 2002. “New Approaches to Analysing Prescription Data and to Transfer Pharmacoepidemiological and Evidence-Based Reports to Prescribers.” Pharmacoepidemiol & Drug Safety 11 (8): 721–6.10.1002/pds.785Search in Google Scholar

Benstetter, F., and A. Wambach. 2006. “The Treadmill Effect in a Fixed Budget System.” Journal of Health Economics 25 (1): 146–69. https://doi.org/10.1016/j.jhealeco.2005.04.004.Search in Google Scholar

Berndt, E. R. 2001. “The U.S. Pharmaceutical Industry: Why Major Growth in Times of Cost Containment?” Health Affairs 20 (2): 100–14.10.1377/hlthaff.20.2.100Search in Google Scholar

Berndt, E.R. 2002. “Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price.” Journal of Economic Perspectives 16 (4): 45–66.10.1257/089533002320950975Search in Google Scholar

Blinder, A. S. 1973. “Wage Discrimination: Reduced Form and Structural Estimates.” Journal of Human Resources 8: 436–55, https://doi.org/10.2307/144855.Search in Google Scholar

Carreras, M., P. Ibern, and J. M. Inoriza. 2018. “Ageing and Healthcare Expenditures: Exploring the Role of Individual Health Status.” Health Economics 27 (5): 865–76. https://doi.org/10.1002/hec.3635.Search in Google Scholar

Chandra, A., and J. Skinner. 2012. “Technology Growth and Expenditures Growth in Health Care.” Journal of Economic Literature 50 (3): 645–80. https://doi.org/10.1257/jel.50.3.645.Search in Google Scholar

Chen, B., and V. Y. Fan. 2015. “Strategic Provider Behavior under Global Budget Payment with Price Adjustment in Taiwan.” Health Economics 24: 1422–36. https://doi.org/10.1002/hec.3095.Search in Google Scholar

Cheng, T. M. 2019. “Health Care Spending in the US and Taiwan: A Response to It’s Still the Prices, Stupid, and a Tribute to Uwe Reinhardt.” Health Affair Blog, https://doi.org/10.1377/hblog20190206.305164.Search in Google Scholar

Cheng, S. H., C. C. Chen, and W. L. Chang. 2009. “Hospital Response to a Global Budget Program under Universal Health Insurance in Taiwan.” Health Policy 92: 158–64. https://doi.org/10.1016/j.healthpol.2009.03.008.Search in Google Scholar

Chernichovsky, D., and S. Markowitz. 2004. “Aging and Aggregate Costs of Medical Care: Conceptual and Policy Issues.” Health Economics 13: 543–62. https://doi.org/10.1002/hec.844.Search in Google Scholar

Chernozhukov, V., I. Fernandez-Val, and B. Melly. 2013. “Inference on Counterfactual Distributions.” Econometrica 81 (6): 2205–68.10.2139/ssrn.1235529Search in Google Scholar

Chien, H. Y., J. J. Ko, Y. C. Chen, S. H. Weng, W. C. Yang, Y. C. Chang, and H. P. Liu. 2013. “Study of Medication Waste in Taiwan.” Journal of Experimental and Clinical Medicine 5 (2): 69–72. https://doi.org/10.1016/j.jecm.2013.02.003.Search in Google Scholar

Chou, S. Y., J. T. Liu, and J. K. Hammitt. 2004. “National Health Insurance and Technology Adoption—Evidence from Taiwan.” Contemporary Economic Policy 22 (1): 26–38. https://doi.org/10.1093/cep/byh003.Search in Google Scholar

Cutler, D. M., and M. McClellan. 1996. “The Determinants of Technological Change in Heart Attack Treatment.” In NBER Working Paper No. 5751.10.3386/w5751Search in Google Scholar

de Meijer, C., O. O’Donnell, M. Koopmanschap, and E. van Doorslaer. 2013. “Health Expenditure Growth: Looking beyond the Average through Decomposition of the Full Distribution.” Journal of Health Economics 32: 88–105. https://doi.org/10.1016/j.jhealeco.2012.10.009.Search in Google Scholar

Denton, F. T., A. Gafni, and B. G. Spencer. 2002. “Exploring the Effects of Population Change on the Costs of Physician Services.” Journal of Health Economics 21: 781–803. https://doi.org/10.1016/s0167-6296(02)00013-9.Search in Google Scholar

DiNardo, J., N. Fortin, and T. Lemieux. 1996. “Labor Market Institutions and the Distribution of Wages, 1973–1992: A Semiparametric Approach.” Econometrica 64: 1001–44. https://doi.org/10.2307/2171954.Search in Google Scholar

Dormont, B., M. Grignon, and H. Huber. 2006. “Health Expenditure Growth: Reassessing the Threat of Aging.” Health Economics 15: 947–63. https://doi.org/10.1002/hec.1165.Search in Google Scholar

Dunn, A., B. Whitmire, A. Batch, L. Fernando, and L. Rittmueller. 2018. “High Spending Growth Rates for Key Diseases in 2000–14 were Driven by Technology and Demographic Factors.” Health Affairs 37 (6): 915–24. https://doi.org/10.1377/hlthaff.2017.1688.Search in Google Scholar

Eggleston, K., and B. M. Yang. 2009. “Physicians and Pharmacists in Comparative Historical Perspective: The Case of South Korea.” In Prescribing Cultures and Pharmaceutical Policy in the Asia Pacific, edited by K. Eggleson, 47–59. Baltimore, MD: Stanford Shorenstein Asia-Pacific Research Center Series with Brookings Institution Press.Search in Google Scholar

Fan, C. P., K. P. Chen, and K. Kan. 1998. “The Design of Payment Systems for Physicians under Global Budget—An Experimental Study.” Journal of Economic Behavior & Organization 34: 295–311. https://doi.org/10.1016/s0167-2681(97)00052-8.Search in Google Scholar

Felder, S., M. Meier, and H. Schmitt. 2000. “Health Care Expenditure in the Last Months of Life.” Journal of Health Economics 19: 679–95. https://doi.org/10.1016/s0167-6296(00)00039-4.Search in Google Scholar

Feldman, R., and F. Lobo. 1997. “Global Budgets and Excess Demand for Hospital Care.” Health Economics 6: 187–96. https://doi.org/10.1002/(sici)1099-1050(199703)6:2<187::aid-hec259>3.0.co;2-w.10.1002/(SICI)1099-1050(199703)6:2<187::AID-HEC259>3.0.CO;2-WSearch in Google Scholar

Firpo, S., N. Fortin, and T. Lemieux. 2009. “Unconditional Quantile Regressions.” Econometrica 77 (3): 953–73.10.3386/t0339Search in Google Scholar

Firpo, S. P., N. M. Fortin, and T. Lemieux. 2018. “Decomposing Wage Distributions Using Recentered Influence Function Regressions.” Econometrics 6 (2): 28. https://doi.org/10.3390/econometrics6020028.Search in Google Scholar

Fortin, N., T. Lemieux, and S. Firpo. 2011. “Decomposition Methods in Economics.” In Handbook of Labor Economics, edited by D. Card, and O. Ashenfelter, 1–102. Amsterdam: Elsevier.10.3386/w16045Search in Google Scholar

Franch, E. B., J. McCauley, M. Aragon, P. Bakx, M. Chalkley, S. H. Chen, B. J. Christensen, H. Chuang, A. Côté-Sergent, M. De Nardi, E. Fan, D. Échevin, P. Y. Geoffard, C. Gastaldi-Ménager, M. Gørtz, Y. Ibuka, J. B. Jones, M. Kallestrup-Lamb, M. Karlsson, T. J. Klein, G. de Lagasnerie, P. C. Michaud, O. O’Donnell, N. Rice, J. S. Skinner, E. van Doorslaer, N. R. Ziebarth, and E. Kelly. 2017. “End-of-Life Medical Spending in Last Twelve Months of Life is Lower than Previously Reported.” Health Affairs 36 (7): 1211–7, https://doi.org/10.1377/hlthaff.2017.0174.Search in Google Scholar

Gavrilov, L. A., and N. S. Gavrilova. 1991. The Biology of Human Life Span: A Quantitative Approach. New York, United States: Harwood Academic Publisher.Search in Google Scholar

Gerdtham, U. G., and D. Lundin. 2004. “Why Did Drug Spending Increase during the 1990s? A Decomposition Based on Swedish Data.” Pharmacoeconomics 22 (1): 29–42.10.2165/00019053-200422010-00003Search in Google Scholar

Gerdtham, U. G., J. Søgaard, F. Andersson, and B. Jonsson. 1992. “An Econometric Analysis of Health Care Expenditure: A Cross-Section Study of the OECD Countries.” Journal of Health Economics 11: 63–84. https://doi.org/10.1016/0167-6296(92)90025-v.Search in Google Scholar

Gerdtham, U. G., M. Johannesson, and B. Jönsson. 1993. “Drug Spending and New Drug Introductions: The Swedish Experience.” PharmacoEconomics 13 (2): 215–25. https://doi.org/10.2165/00019053-199304030-00006.Search in Google Scholar

Gerdtham, U. G., B. Jönsson, M. MacFarlan, and H. Oxley. 1998. “The Determinants of Health Expenditure in the OECD Countries: A Pooled Data Analysis.” In Health, the Medical Profession, and Regulation, Vol. 6, edited by P. Zweifel, 113–34. New York, NY: Springer.10.1007/978-1-4615-5681-7_6Search in Google Scholar

Getzen, T. E. 1992. “Population Aging and the Growth of Health Expenditures.” Journal of Gerontology 47: S98–104. https://doi.org/10.1093/geronj/47.3.s98.Search in Google Scholar

Häkkinen, U., P. Martikainen, A. Noro, E. Nihtilä, and M. Peltola. 2008. “Aging, Health Expenditure, Proximity to Death, and Income in Finland.” Health Economics, Policy and Law 3: 165–95. https://doi.org/10.1017/s174413310800443x.Search in Google Scholar

Hitiris, T., and J. Posnett. 1992. “The Determinants and Effects of Health Expenditure in Developed Countries.” Journal of Health Economics 11: 173–81. https://doi.org/10.1016/0167-6296(92)90033-w.Search in Google Scholar

Hsieh, C. R., and F. A. Sloan. 2008. “Adoption of Pharmaceutical Innovation and the Growth of Drug Expenditure in Taiwan: Is It Cost Effective?” Value in Health 11 (2): 334–44.10.1111/j.1524-4733.2007.00235.xSearch in Google Scholar

Hsu, W. C., and Y. P. Hsu. 2016. “Patterns of Outpatient Care Utilization by Seniors under the National Health Insurance in Taiwan.” Journal of the Formosan Medical Association 115 (5): 325–34. https://doi.org/10.1016/j.jfma.2015.12.001.Search in Google Scholar

Huang, Y., and Y. Yang. 2009. “Pharmaceutical Pricing in China.” In Prescribing Cultures and Pharmaceutical Policy in the Asia Pacific, edited by K. Eggleson, 205–22. Baltimore, MD: Stanford Shorenstein Asia-Pacific Research Center Series with Brookings Institution Press.Search in Google Scholar

Iizuka, T. 2007. “Experts’ Agency Problems: Evidence from the Prescription Drug Market in Japan.” The RAND Journal of Economics 38 (3): 844–62. https://doi.org/10.1111/j.0741-6261.2007.00115.x.Search in Google Scholar

Iizuka, T. 2009. “The Economics of Pharmaceutical Pricing and Physician Prescribing in Japan.” In Prescribing Cultures and Pharmaceutical Policy in the Asia Pacific, edited by K. Eggleson, 47–59. Baltimore, MD: Stanford Shorenstein Asia-Pacific Research Center Series with Brookings Institution Press.10.2139/ssrn.1156608Search in Google Scholar

Iizuka, T. 2012. “Physician Agency and the Adoption of Generic Pharmaceuticals.” The American Economic Review 102 (6): 2826–58. https://doi.org/10.1257/aer.102.6.2826.Search in Google Scholar

Lee, Y. C., M. C. Yang, Y. T. Huang, C. H. Liu, and S. B. Chen. 2006. “Impacts of the Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan 1997–2003.” PharmacoEconomics 24 (9): 891–902. https://doi.org/10.2165/00019053-200624090-00006.Search in Google Scholar

Lee, Y. C., K. H. Huang, and Y. T. Huang. 2007. “Adverse Pharmaceutical Incentive and Providers’ Behavior: The Emergence of the GP-Owned Gateway Pharmacies in Taiwan.” Health Policy and Planning 22: 427–35. https://doi.org/10.1093/heapol/czm035.Search in Google Scholar

Leu, R. E. 1986. “The Public-Private Mix and International Health Care Costs.” In Public and Private Health Services: Complementarities and Conflicts, edited by A. J. Culyer, and B. Jönsson, 41–63. Hoboken, NJ: Blackwell Scientific Publications.Search in Google Scholar

Liu, Y. M., Y. H. K. Yang, and C. R. Hsieh. 2009. “Financial Incentives and Physicians’ Prescription Decisions on the Choice between Brand-Name and Generic Drugs: Evidence from Taiwan.” Journal of Health Economics 28: 341–9. https://doi.org/10.1016/j.jhealeco.2008.10.009.Search in Google Scholar

Liu, Y. M., Y. H. K. Yang, and C. R. Hsieh. 2012. “Regulation and Competition in the Taiwanese Pharmaceutical Market under National Health Insurance.” Journal of Health Economics 31: 471–83. https://doi.org/10.1016/j.jhealeco.2012.03.003.Search in Google Scholar

Liu, Y. M., and C. R. Hsieh. 2014. “Profit-Seeking Behavior of Medical Providers and Generic Competition in the Pharmaceutical Market: Evidence from Taiwan.” The B.E. Journal of Economic Analysis & Policy 14 (1): 241–75. https://doi.org/10.1515/bejeap-2013-0066.Search in Google Scholar

Liu, Y. M. 2020. “Understanding Profit Margins of Medical Providers from Prescription Drugs: Evidence from Taiwan.” International Health 12 (4): 272–80. https://doi.org/10.1093/inthealth/ihz072.Search in Google Scholar

Lu, J. R., and T. L. Chiang. 2011. “Evolution of Taiwan’s Health Care System.” Health Economics, Policy and Law 6: 85–107. https://doi.org/10.1017/s1744133109990351.Search in Google Scholar

Ministry of Health and Welfare (MHW). 2015. National Health Expenditure 2015. https://dep.mohw.gov.tw/DOS/lp-2830-113.html (accessed January 13, 2021).Search in Google Scholar

Ministry of Health and Welfare (MHW), R.O.C. (Taiwan). 2012. Statistical Annual Report of Medical Care, National Health Insurance. Ministry of Health and Welfare. https://dep.mohw.gov.tw/DOS/np-1982-113.html (accessed March 7, 2020).Search in Google Scholar

Ministry of Health and Welfare (MHW), R.O.C. (Taiwan). 2015. National Health Expenditure 2015. Ministry of Health and Welfare. https://dep.mohw.gov.tw/DOS/lp-2830-113.html (accessed January 13, 2021).Search in Google Scholar

Ministry of Health and Welfare (MHW), R.O.C. (Taiwan). 2019. Statistical Annual Report of Medical Care, National Health Insurance. Ministry of Health and Welfare. https://www.mohw.gov.tw/dl-70641-33764b1d-b662-4c0c-b01a-e57bd6949084.html (accessed October 17, 2021).Search in Google Scholar

Morgan, S. G. 2002. “Quantifying Components of Drug Expenditure Inflation: The British Columbia Seniors’ Drug Benefit Plan.” Health Services Research 37 (5): 1243–66.10.1111/1475-6773.01058Search in Google Scholar

Mukherjee, B., H. T. Ou, F. Wang, and S. R. Erickson. 2011. “A New Comorbidity Index: The Health-Related Quality of Life Comorbidity Index.” Journal of Clinical Epidemiology 64 (3): 309–19. https://doi.org/10.1016/j.jclinepi.2010.01.025.Search in Google Scholar

National Health Insurance Administration (NHIA). 2005. Professional Monitoring Measures of Hospital Global Budget 2005. https://www.nhi.gov.tw/DL.aspx?sitessn=292&u=LzAwMS9VcGxvYWQvT2xkRmlsZS9OaGlQdWJXZWIvcmVzb3VyY2UvV2ViZGF0YS9BdHRhY2hfNDMyMl8xXzk0MDgyNS0zLnBkZg%3D%3D&n=QXR0YWNoXzQzMjJfMV85NDA4MjUtMy5wZGY%3D&ico%20=.pdf (accessed January 22, 2021).Search in Google Scholar

National Health Insurance Administration (NHIA). 2017. 2017–2018 National Health Insurance Annual Report, 36–9. https://ws.nhi.gov.tw/001/Upload/293/RelFile/Ebook/English.pdf (accessed August 12, 2022).Search in Google Scholar

Newhouse, J. P. 1992. “Medical Care Costs: How Much Welfare Loss?” The Journal of Economic Perspectives 6 (3): 3–21. https://doi.org/10.1257/jep.6.3.3.Search in Google Scholar

Oaxaca, R. 1973. “Male–Female Wage Differentials in Urban Labor Markets.” International Economic Review 14: 693–709. https://doi.org/10.2307/2525981.Search in Google Scholar

O’Connell, J. 1996. “The Relationship between Health Expenditures and the Age Structure of the Population in OECD Countries.” Health Economics 5: 573–8. https://doi.org/10.1002/(sici)1099-1050(199611)5:6<573::aid-hec231>3.0.co;2-l.10.1002/(SICI)1099-1050(199611)5:6<573::AID-HEC231>3.0.CO;2-LSearch in Google Scholar

Organization for Economic Co-operation and Development (OECD). 2014. OECD Health Statistics. http://www.oecd.org/els/health-systems/oecd-health-statistics-2014-frequently-requested-data.htm (accessed January 22, 2021).Search in Google Scholar

Peden, E. A., and M. S. Freeland. 1995. “A Historical Analysis of Medical Spending Growth, 1960–1993.” Health Affairs 14 (2): 235–47. https://doi.org/10.1377/hlthaff.14.2.235.Search in Google Scholar

Scitovsky, A. A. 1985. “Changes in the Costs of Treatment of Selected Illnesses.” Medical Care Research and Review 23 (2): 1245–57. https://doi.org/10.1097/00005650-198512000-00004.Search in Google Scholar

Scitovsky, A. A., and N. McCall. 1976. Changes in Treatment Costs for Selected Illnesses, 1951–1964–1971. Washington DC: US Department of Health Education and Welfare, National Center for Health Services Research.Search in Google Scholar

Schmid, C. P. R. 2017. “Unobserved Health Care Expenditures: How Important is Censoring in Register Data?” Health Economics 26 (12): 1807–12. https://doi.org/10.1002/hec.3504.Search in Google Scholar

Schwartz, W. B. 1987. “The Inevitable Failure of Current Cost-Containment Strategies: Why they can Provide Only Temporary Relief.” Journal of the American Medical Association 257 (2): 220–4. https://doi.org/10.1001/jama.1987.03390020086032.Search in Google Scholar

Seshamani, M., and A. Gray. 2004a. “Ageing and Health-Care Expenditure: The Red Herring Argument Revisited.” Health Economics 13: 303–14. https://doi.org/10.1002/hec.826.Search in Google Scholar

Seshamani, M., and A. Gray. 2004b. “A Longitudinal Study of the Effects of Age and Time to Death on Hospital Costs.” Journal of Health Economics 23: 217–35. https://doi.org/10.1016/j.jhealeco.2003.08.004.Search in Google Scholar

Shang, B., and D. Goldman. 2008. “Does Age or Life Expectancy Better Predict Health Care Expenditure?” Health Economics 17: 487–501. https://doi.org/10.1002/hec.1295.Search in Google Scholar

Showstack, J. A., S. A. Schroeder, and M. F. Matsumoto. 1982. “Changes in the Use of Medical Technologies, 1972–1977.” New England Journal of Medicine 15: 124–33. https://doi.org/10.1056/nejm198203253061203.Search in Google Scholar

van Baal, P., and A. Wong. 2012. “Time to Death and Forecasting of Macro-Level Health Care Expenditures: Some Further Considerations.” Journal of Health Economics 31: 876–87. https://doi.org/10.1016/j.jhealeco.2012.08.003.Search in Google Scholar

Word Health Organization (WHO). 2020. Global Health Expenditure Database: Current Health Expenditure. https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS(accessed January 22, 2021).Search in Google Scholar

Zweifel, P., S. Felder, and M. Meiers. 1999. “Aging of Population and Health Care Expenditure: A Red Herring?” Health Economics 8: 485–96. https://doi.org/10.1002/(sici)1099-1050(199909)8:6<485::aid-hec461>3.0.co;2-4.10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4Search in Google Scholar